Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew M Farrar

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Experimental Neurology|August 26, 2011
Reduced striatal acetylcholine efflux in the R6/2 mouse model of Huntington's disease: an examination of the role of altered inhibitory and excitatory mechanismsAndrew M Farrar, Joshua W Callahan, Elizabeth D Abercrombie
Pharmacology, Biochemistry, and Behavior|February 19, 2008
Systemic administration of the adenosine A(2A) agonist CGS 21680 induces sedation at doses that suppress lever pressing and food intakeSusana Mingote, Mariana Pereira, Andrew M Farrar, et al.
Frontiers in Behavioral Neuroscience|October 15, 2009
Dopamine, behavioral economics, and effortJohn D Salamone, Merce Correa, Andrew M Farrar, et al.
Behavioural Processes|October 29, 2003
Effects of reinforcer magnitude on an animal model of impulsive behaviorAndrew M. Farrar, Artur K. Kieres, Kathryn A. Hausknecht, et al.
Psychopharmacology|October 31, 2006
Adenosine A(2A) receptor antagonism reverses the effects of dopamine receptor antagonism on instrumental output and effort-related choice in the rat: implications for studies of psychomotor slowingAndrew M Farrar, Mariana Pereira, Francisco Velasco, et al.
Psychopharmacology|September 18, 2010
Effect of the adenosine A2A receptor antagonist MSX-3 on motivational disruptions of maternal behavior induced by dopamine antagonism in the early postpartum ratMariana Pereira, Andrew M Farrar, Jörg Hockemeyer, et al.
Disease-A-Month : DM|January 15, 2025
Ecstasy, molly, MDMA: What health practitioners need to know about this common recreational drugAndrew M Farrar, Isabelle H Nordstrom, Kaitlyn Shelley, et al.
Psychopharmacology|January 31, 2004
Effects of morphine and naltrexone on impulsive decision making in ratsArtur K Kieres, Kathryn A Hausknecht, Andrew M Farrar, et al.
The European Journal of Neuroscience|June 11, 2009
In-vitro analysis of Pitx3 in mesodiencephalic dopaminergic neuron maturationTheodora Papanikolaou, Tomokazu Amano, Jessica Lennington, et al.
Psychopharmacology|December 3, 2008
The adenosine A2A antagonist MSX-3 reverses the effort-related effects of dopamine blockade: differential interaction with D1 and D2 family antagonistsLila T Worden, Mona Shahriari, Andrew M Farrar, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Experimental Neurology|August 26, 2011
Reduced striatal acetylcholine efflux in the R6/2 mouse model of Huntington's disease: an examination of the role of altered inhibitory and excitatory mechanismsAndrew M Farrar, Joshua W Callahan, Elizabeth D Abercrombie
Pharmacology, Biochemistry, and Behavior|February 19, 2008
Systemic administration of the adenosine A(2A) agonist CGS 21680 induces sedation at doses that suppress lever pressing and food intakeSusana Mingote, Mariana Pereira, Andrew M Farrar, et al.
Frontiers in Behavioral Neuroscience|October 15, 2009
Dopamine, behavioral economics, and effortJohn D Salamone, Merce Correa, Andrew M Farrar, et al.
Behavioural Processes|October 29, 2003
Effects of reinforcer magnitude on an animal model of impulsive behaviorAndrew M. Farrar, Artur K. Kieres, Kathryn A. Hausknecht, et al.
Psychopharmacology|October 31, 2006
Adenosine A(2A) receptor antagonism reverses the effects of dopamine receptor antagonism on instrumental output and effort-related choice in the rat: implications for studies of psychomotor slowingAndrew M Farrar, Mariana Pereira, Francisco Velasco, et al.
Psychopharmacology|September 18, 2010
Effect of the adenosine A2A receptor antagonist MSX-3 on motivational disruptions of maternal behavior induced by dopamine antagonism in the early postpartum ratMariana Pereira, Andrew M Farrar, Jörg Hockemeyer, et al.
Disease-A-Month : DM|January 15, 2025
Ecstasy, molly, MDMA: What health practitioners need to know about this common recreational drugAndrew M Farrar, Isabelle H Nordstrom, Kaitlyn Shelley, et al.
Psychopharmacology|January 31, 2004
Effects of morphine and naltrexone on impulsive decision making in ratsArtur K Kieres, Kathryn A Hausknecht, Andrew M Farrar, et al.
The European Journal of Neuroscience|June 11, 2009
In-vitro analysis of Pitx3 in mesodiencephalic dopaminergic neuron maturationTheodora Papanikolaou, Tomokazu Amano, Jessica Lennington, et al.
Psychopharmacology|December 3, 2008
The adenosine A2A antagonist MSX-3 reverses the effort-related effects of dopamine blockade: differential interaction with D1 and D2 family antagonistsLila T Worden, Mona Shahriari, Andrew M Farrar, et al.
Pageof 2